SEC Form 4 · accession 0001567619-18-002904
NEVRO CORP · NVRO
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Rami Elghandour
Officer — President & CEO · Director
Period of report
Sep 17, 2018
Accepted (ET)
Sep 19, 2018 · 7:05 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001444380
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Sep 17, 2018 | M | 18,400 | $3.60 | A | 129,653 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to buy)F2 | $3.60 | Sep 17, 2018 | M | 18,400 | D | — | Dec 17, 2022 | Common Stock | 18,400 | 101,146 | D |
Explanation of responses
- F1Includes 90,381 RSUs.
- F2The option is fully vested and exercisable.